Moore Capital Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.16M	Hold	35,000	–	–	0.01%	321
2025 Q1	$1.41M	Hold	35,000	–	–	0.03%	247
2024 Q4	$1.65M	Hold	35,000	–	–	0.02%	263
2024 Q3	$1.85M	Hold	35,000	–	–	0.03%	250
2024 Q2	$1.9M	Hold	35,000	–	–	0.03%	241
2024 Q1	$2.45M	Buy	35,000 +30,000	+600%	+$2.1M	0.04%	211
2023 Q4	$417K	Sell	5,000 -20,000	-80%	-$1.67M	0.01%	275
2023 Q3	$737K	Hold	25,000	–	–	0.01%	256
2023 Q2	$816K	Hold	25,000	–	–	0.01%	283
2023 Q1	$880K	Hold	25,000	–	–	0.02%	277
2022 Q4	$1.15M	Hold	25,000	–	–	0.03%	301
2022 Q3	$1.21M	Sell	25,000 -25,000	-50%	-$1.21M	0.03%	383
2022 Q2	$1.97M	Sell	50,000 -25,000	-33%	-$983K	0.05%	316
2022 Q1	$2.76M	Sell	75,000 -25,000	-25%	-$920K	0.07%	297
2021 Q4	$4.56M	Buy	+100,000	New	+$4.56M	0.09%	231
2020 Q4	–	Sell	-50,000	Closed	-$1.08M	–	517
2020 Q3	$1.08M	Buy	+50,000	New	+$1.08M	0.02%	268
2017 Q3	–	Sell	-50,000	Closed	-$605K	–	210
2017 Q2	$605K	Buy	+50,000	New	+$605K	0.02%	156